159 related articles for article (PubMed ID: 23463477)
1. [Aspirin-exacerbated respiratory disease].
Randerath WJ
Dtsch Med Wochenschr; 2013 Mar; 138(11):541-7. PubMed ID: 23463477
[TBL] [Abstract][Full Text] [Related]
2. Aspirin-exacerbated respiratory disease: update on pathogenesis and desensitization.
White AA; Stevenson DD
Semin Respir Crit Care Med; 2012 Dec; 33(6):588-94. PubMed ID: 23047310
[TBL] [Abstract][Full Text] [Related]
3. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease.
Berges-Gimeno MP; Simon RA; Stevenson DD
Ann Allergy Asthma Immunol; 2002 Nov; 89(5):474-8. PubMed ID: 12452205
[TBL] [Abstract][Full Text] [Related]
4. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
Ledford DK; Wenzel SE; Lockey RF
J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
[TBL] [Abstract][Full Text] [Related]
5. Phenomenology, pathogenesis, diagnosis and treatment of aspirin-sensitive rhinosinusitis.
Schapowal AG; Simon HU; Schmitz-Schumann M
Acta Otorhinolaryngol Belg; 1995; 49(3):235-50. PubMed ID: 7484142
[TBL] [Abstract][Full Text] [Related]
6. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
White AA; Stevenson DD; Simon RA
Ann Allergy Asthma Immunol; 2005 Oct; 95(4):330-5. PubMed ID: 16279562
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey.
Bavbek S; Yilmaz I; Celik G; Aydin O; Erkekol FÖ; Orman A; Kurt E; Ediger D; Dursun B; Abadoğlu O; Ozşeker F; Akkaya E; Karakiş GP; Canbakan S; Yüksel S; Misirligil Z
Allergol Immunopathol (Madr); 2012; 40(4):225-30. PubMed ID: 21889254
[TBL] [Abstract][Full Text] [Related]
8. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis.
Bochenek G; Kuschill-Dziurda J; Szafraniec K; Plutecka H; Szczeklik A; Nizankowska-Mogilnicka E
J Allergy Clin Immunol; 2014 Jan; 133(1):98-103.e1-6. PubMed ID: 23993879
[TBL] [Abstract][Full Text] [Related]
9. Aspirin and salicylate in respiratory disease.
Mitchell JE; Skypala I
Rhinology; 2013 Sep; 51(3):195-205. PubMed ID: 23943725
[TBL] [Abstract][Full Text] [Related]
10. [Aspirin sensitivity: long term follow-up after up to 3 years of adaptive desensitization using a maintenance dose of 100 mg of aspirin a day].
Gosepath J; Schäfer D; Mann WJ
Laryngorhinootologie; 2002 Oct; 81(10):732-8. PubMed ID: 12397524
[TBL] [Abstract][Full Text] [Related]
11. Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease.
Stevenson DD; Mehra PK; White AA; Gupta S; Woessner KM; Simon RA
J Allergy Clin Immunol; 2005 Oct; 116(4):755-60. PubMed ID: 16210047
[TBL] [Abstract][Full Text] [Related]
12. Alcohol-induced respiratory symptoms improve after aspirin desensitization in patients with aspirin-exacerbated respiratory disease.
Glicksman JT; Parasher AK; Doghramji L; Brauer D; Waldram J; Walters K; Bulva J; Palmer JN; Adappa ND; White AA; Bosso JV
Int Forum Allergy Rhinol; 2018 Oct; 8(10):1093-1097. PubMed ID: 30007020
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of aspirin hypersensitivity in patients with nasal polyposis and contributing factors.
Bavbek S; Dursun B; Dursun E; Korkmaz H; Sertkaya Karasoy D
Am J Rhinol Allergy; 2011; 25(6):411-5. PubMed ID: 22185746
[TBL] [Abstract][Full Text] [Related]
14. Comorbid diseases in aspirin-exacerbated respiratory disease, and asthma.
Erdogan T; Karakaya G; Kalyoncu AF
Allergol Immunopathol (Madr); 2015; 43(5):442-8. PubMed ID: 25547458
[TBL] [Abstract][Full Text] [Related]
15. [Aspirin-Intolerance-Syndrom : a common and interdisciplinary disease].
Umbreit C; Virchow JC; Thorn C; Hörmann K; Klimek L; Pfaar O
Internist (Berl); 2010 Sep; 51(9):1196-8, 1200-1. PubMed ID: 20725708
[TBL] [Abstract][Full Text] [Related]
16. Aspirin-Exacerbated Respiratory Disease.
Walgama ES; Hwang PH
Otolaryngol Clin North Am; 2017 Feb; 50(1):83-94. PubMed ID: 27888917
[TBL] [Abstract][Full Text] [Related]
17. Cortactin expression in nasal polyps of Aspirin-Exacerbated Respiratory Disease (AERD) patients.
Brescia G; Parrino D; Nicolè L; Zanotti C; Lanza C; Barion U; Marino F; Marioni G
Am J Otolaryngol; 2018; 39(3):293-298. PubMed ID: 29534838
[TBL] [Abstract][Full Text] [Related]
18. The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges.
Williams AN; Simon RA; Woessner KM; Stevenson DD
J Allergy Clin Immunol; 2007 Aug; 120(2):273-7. PubMed ID: 17481713
[TBL] [Abstract][Full Text] [Related]
19. Aspirin hypersensitivity in patients with chronic rhinosinusitis and nasal polyposis: frequency and contributing factors.
Nabavi M; Esmaeilzadeh H; Arshi S; Bemanian MH; Fallahpour M; Bahrami A; Mortazavi N; Kamrava K; Farhadi M; Taghipour R; Rezaei N
Am J Rhinol Allergy; 2014; 28(3):239-43. PubMed ID: 24980235
[TBL] [Abstract][Full Text] [Related]
20. Nonsteroidal anti-inflammatory drugs-exacerbated respiratory disease in adolescents.
Ertoy Karagol HI; Yilmaz O; Topal E; Ceylan A; Bakirtas A
Int Forum Allergy Rhinol; 2015 May; 5(5):392-8. PubMed ID: 25755210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
